David Shaywitz, Contributor

Author's posts

Pharma’s Desperate Struggle To Teach Old Data New Tricks

In pharma R&D organizations and in hospital systems, any effort to glean novel insight from existing data represents a maddeningly difficult challenge.

How Big Pharmas Simultaneously Repel And Embrace Innovation

So often, the experience of innovation at large pharmas can be disappointing and stifling, but occasionally, under the right circumstances, it is transformative and elating.

Why Health Tech Entrepreneurs Should Visit Michaels

Art supply store Michaels offers an elegant, technology-enabled approach to picture framing that offers three lessons for health tech entrepreneurs.

Why Health Tech Entrepreneurs Should Visit Michaels

Art supply store Michaels offers an elegant, technology-enabled approach to picture framing that offers three lessons for health tech entrepreneurs.

Digital Medicine: Digital Health, Plus Evidence, Plus Humility

I see a new generation of researchers who grew up immersed in data+digital beginning to populate incumbent healthcare organizations+pharma companies, bringing with them a new set of expectations+capabilities. With time, effort, and a bit of luck, I sus…

Cancer Research Meeting Offers Cambrian Explosion of Biology, Opportunity For Data Science

This is a profoundly exciting and dynamic time in cancer research, as recent biological advances have revealed a range of therapeutic avenues and generated a palpable sense of hope and possibility. I am also encouraged by efforts utilizing data and tec…

Enough With Culture — Focus On Structure, Biotech Entrepreneur Argues

Pharma desperately needs innovation; the question Safi Bahcall’s new book begs is whether senior pharma executives can structure their organizations in a fashion can liberate the creativity, and tolerate the uncertainty, innovation requires.

Amy Abernethy For FDA Commissioner

If appointed by President Trump to lead the FDA, Dr. Amy Abernethy would be a credit to the Administration, the Agency, and – mostly importantly – to the patients who would benefit from her vision, compassion, determination, and insight.

What Is A Data Science Mindset — And Does Pharma R&D Really Need One?

Data scientists are optimistic about the opportunity to improve how new medicines are discovered; most traditional medical scientists (including most pharma researchers) are skeptical these new approaches will deliver benefit to patients, but convincib…

Hard Lessons For Would-Be Healthcare Innovators From UCSF Expert

Tech entrepreneurs should work closely with front-line innovators to ensure their company is focused on a relevant problem and developing an implementable solution; innovators must also recognize that robust evidence of impact (not just clicks) is esse…